
Michael Ameer Weintraub MD
Diabetes, Obesity, Pituitary Disorders & Neuroendocrinology
Physician
Join to View Full Profile
222 E 41st StNew York, NY 10017
Phone+1 212-481-1350
Fax+1 212-481-1355
Dr. Weintraub is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Michael Weintraub is an endocrinologist in New York, NY and is affiliated with New York-Presbyterian Hospital. He received his medical degree from Rutgers Robert Wood Johnson Medical School. He specializes in diabetes, obesity, and pituitary disorders & neuroendocrinology. He has 6 publications and 18 citings.
Education & Training
- Rutgers Robert Wood Johnson Medical SchoolClass of 2017
Certifications & Licensure
- NY State Medical License 2022 - 2025
- PA State Medical License 2017 - 2022
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
- American Board of Obesity Medicine Obesity Medicine
Publications & Presentations
PubMed
- 1 citationsGLP-1 receptor agonists in kidney transplant recipients with pre-existing diabetes: a retrospective cohort study.Babak J Orandi, Yusi Chen, Yiting Li, Garyn T Metoyer, Krista L Lentine
The Lancet. Diabetes & Endocrinology. 2025-05-01 - Nasal resistance and inflammation: mechanisms for obstructive sleep apnea from chronic rhinosinusitis.Indu Ayappa, Robert Laumbach, Kathleen Black, Michael Weintraub, Priya Agarwala
Journal of Clinical Sleep Medicine. 2024-10-01 - Third-Line Overactive Bladder Therapies on TikTok: What Does the Public Learn?Alexandra L Tabakin, Sharon Choi, Arshia Sandozi, Kelli Aibel, Michael A Weintraub
Urogynecology. 2024-06-01
Press Mentions
- Study Shows Benefits of GLP-1 Drugs for Kidney Transplant Recipients with Type 2 DiabetesMarch 4th, 2025
- ‘Vicious Cycle’: Are There Benefits to ‘Yo-Yo Dieting?’January 27th, 2025
- Obesity Dipped in U.S. Adults Last Year for the First Time in More Than a DecadeDecember 13th, 2024
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: